Verified Analyst Curated

Company Overview — Company Profile

8 pages · Historical 2022–2025 · Forecast 2025–2031

USD 499.00

PDF download · Immediate access

Overview

Hamont-Achel, founded in 1994, specialising in the design, manufacture, and distribution of minimally invasive gynaecological and assisted reproductive technology (ART) devices. European medtech ecosystem, with a primary focus on intrauterine device (IUD) insertion systems, embryo transfer catheters, and related consumables used across IVF clinical pathways. Western Europe, the Middle East, and select Asia-Pacific markets, served through a hybrid direct-sales and distributor network model.

Table of Contents

  • Company Overview & Strategy
  • Financial Performance (2022–2024)
  • Product Portfolio
  • SWOT Analysis